Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- P.L. Thomas and Laila Impex Announce Strategic Alliance
Alliance formally recognizes commitment to an intensified and united approach to advanced ingredient discoveries.
- P.L. Thomas and Laila Impex Announce Strategic Alliance
Alliance formally recognizes commitment to an intensified and united approach to advanced ingredient discoveries.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Symrise Acquires English Flavor Manufacturer Flavours Direct
Company will acquire the British flavor manufacturer Flavours Direct as of 31st of March 2005; deal intended to strengthen its position in Great Britain and Ireland, and to make the company one of the foremost suppliers of savory flavors in Great Britain.
- Symrise Acquires English Flavor Manufacturer Flavours Direct
Company will acquire the British flavor manufacturer Flavours Direct as of 31st of March 2005; deal intended to strengthen its position in Great Britain and Ireland, and to make the company one of the foremost suppliers of savory flavors in Great Britain.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- Hansen Natural Corporation Reports Record Financial Results for 2004
Company reports net sales of $180.3 million compared to $110.4 million the prior year, while net income grew from $5.9 million, or $0.55 per diluted share to $20.4 million, or $1.73 per diluted share; results due in large part to increased sales volumes of Monster Energy(R) drinks and Lo-Carb Monster Energy(R) drinks.
- Hansen Natural Corporation Reports Record Financial Results for 2004
Company reports net sales of $180.3 million compared to $110.4 million the prior year, while net income grew from $5.9 million, or $0.55 per diluted share to $20.4 million, or $1.73 per diluted share; results due in large part to increased sales volumes of Monster Energy(R) drinks and Lo-Carb Monster Energy(R) drinks.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Frutarom Reports 2004 Results
Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million.
- Frutarom Reports 2004 Results
Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- ON's Pro Complex® Augmented Protein System Goes Natural
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
Trace Minerals Research is now offering a new and improved formula of Electrolyte Stamina Tablets, an electrolyte replacement supplement designed for individuals that expend large amounts of electrolytes during strenuous activities. Electrolyte Stamina Tablets now contain P-5-P and L-Taurine.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3
Natural Nutrition, Inc., has reported net income of $2,062,452 (unaudited) for the first nine months of 2008 through September 30th versus losses of $3,744,404 through the same first nine months of 2007. These numbers are unaudited and subject to revision.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Nutraceutical Reports FY08 End Results
Nutraceutical International Corporation has announced the results for the fiscal 2008 fourth quarter and year ended September 30, 2008. Net sales for the fiscal year ended September 30, 2008 were $166.9 million compared to $156.5 million for fiscal 2007. For fiscal 2008, net income was $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 diluted earnings per share (including the goodwill impairment charge of $0.16 per share), compared to net income of $13.0 million (including the $0.3 million intangible asset impairment charge), or $1.15 diluted earnings per share (including the intangible asset impairment charge of $0.02 per share), for fiscal 2007.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition
Health ingredients Europe and Natural ingredients 2008, the global events for the health and natural ingredients industries, recorded more than a 7%* increase in attendance at the biennial event, which took place on 4-6 November 2008 in Paris, France.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Lifeway Foods Announces New West Coast Distribution
Lifeway Foods, Inc., has announced new distribution of its ProBugs(TM) Organic Kefir in the northern California region through Costco. ProBugs(TM) Organic Kefir, which is geared towards children, comes in a patented no-spill pouch and will be sold in a twelve unit multi-pack consisting of kid friendly flavors, Orange Creamy Crawler(TM) and Goo Berry Pie(TM). Shipments will begin in the third week of December 2008.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients
Symrise has acquired licenses for two new groups of cosmetic active ingredients. These promising results were achieved in a joint development project with biotech specialist BRAIN and natural-product company AnalytiCon. The license gives Symrise international marketing rights.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- Mannatech Declares Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a quarterly cash dividend on Wednesday, November 19, 2008 of $0.02 per share of common stock payable on Monday, December 29, 2008, to shareholders of record at the close of business on Thursday, December 11, 2008.
- NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment
Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
- NPI Daily - Top of The News for November 20, 2008 - Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment
Symrise Obtains Exclusive Marketing Rights to New Cosmetic Active Ingredients; Natural Nutrition Reports Comprehensive Income of $2,062,452 Through FY08 Q3; Nutraceutical Reports FY08 End Results; Mannatech Declares Dividend; Hi Europe & Ni 2008 Attendance Grows 7% on Previous Edition; Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium; Marketers of Dietary Supplements Ordered to Halt False Claims About Diabetes Prevention and Treatment; PC Brands Introduces Shelf-Stable Nutrition Bar With Probiotics; Lifeway Foods Announces New West Coast Distribution; Trace Minerals Research Releases New and Improved Performance Electrolyte Formula
|
EuroPharma Narrows Focus to Product Development, Innovation
Green Bay, WI (March 15, 2005) – EuroPharma’s president Terry Lemerond today signed a licensing and distribution agreement with the company he founded and brought to prominence almost 25 years ago, Enzymatic Therapy. Beginning this week at Natural Products Expo West, Enzymatic Therapy will take over marketing, sales and distribution of EuroPharma’s SneezEze and Renouvelle products. The companies anticipate partnering on additional innovative products in the future.
Innovation is the key to success in any industry, but particularly in the dietary supplements and natural products arena. Terry Lemerond is known for pioneering new products, categories and methods, and has continued on that path with EuroPharma, the company he founded three years ago after selling Enzymatic Therapy.
“Starting from scratch, building a new business is always challenging, interesting, and a lot of fun but after three years EuroPharma has made a decision to pursue our true passion.” Lemerond said. “The past history of our EuroPharma team, even when at Enzymatic Therapy, was steeped in innovation, creativity, and the development of new products. For example Lemerond’s introduction of Glucosamine Sulfate, IP-6, the menopause category, standardization of herbal extracts, and complex formulations were all firsts in the industry.
The development of new products never presented a challenge to the EuroPharma team. In fact, they came up with so many new ideas that it was impossible for a company that size to market all of them successfully. So rather than spending their resources on developing a larger infrastructure it made sense to partner with those companies who excel in marketing, sales, and distribution, yet seek new product development expertise.
So to launch the company’s new, more specific focus, EuroPharma will partner with Enzymatic Therapy for EuroPharma’s flagship products. With many more products in the pipeline, EuroPharma will continue to work with Enzymatic Therapy, as well as source additional partnerships for the other new products when appropriate.
True to the company’s track record of introducing category-changing supplements, one of the most exciting products in the EuroPharma pipeline is a patented Joint/Anti-Inflammatory product for which the company has exclusive licensing for North America. It is clinically studied for its anti-inflammatory relief of osteoarthritis, is more effective than glucosamine and will be the next generation in joint health.
Other products under development include the most powerful carb blocker, a safe and effective fat blocker, and a highly effective anti-viral product. Research is underway for an herbal digestive; a unique Indian botanical that improves muscle mass for athletes and for those recovering from serious illnesses; and a product for regulation of blood sugar. EuroPharma is collaborating with a company on an immune modulator that is showing to be 100 times stronger than anything else in the market today.
“With the completion of the research on each of our new botanicals we can verify effectiveness, safety, complete toxicology, pharmacology and provide clinical studies to support the marketing of these new botanical products.” Lemerond said. “By partnering these and other products with highly reputable companies we can significantly impact the growth of the natural products industry. We will help these companies launch new and exclusive products based on the latest scientific evidence. We see an enormous opportunity to bring new life and energy to the new products arena; products that are based on science and meet the guidelines of the FDA and FTC. “
EuroPharma has an extensive resource network of industry scientists, innovators, and experts in the U.S., Europe and Asia as a result of the business relationships and friendships established by Mr. Lemerond through extensive travel in Europe and Asia over the past several decades. This includes a partnership with a biotech firm in Europe that develops new ingredients and products exclusively for EuroPharma. This firm also provides the toxicology, pharmacology, and efficacy data to support the desired health claims.
Located in Green Bay, Wisconsin, EuroPharma, Inc., is a European-inspired company with a mission to bring truly unique and industry changing products to the U.S. marketplace. EuroPharma is committed to discovering innovative products that have been thoroughly researched and demonstrated to be safe, natural and effective which will help people live healthier and more fulfilling lives. EuroPharma is an extension of its founder, Terry Lemerond’s historic successes and a proven model of product development. For more information, visit www.EuroPharmaUSA.com.
- END -
Contact:
Suzanne Shelton 847-676-4337
Suzanne@SheltonGroupPR.com |